Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 36
- Companies
Little Green Pharma signs €1.4m agreement for German cannabis supply
The company now has its products distributed in a number of European countries including the UK, Italy and Denmark.
- Uncategorized
Little Green Pharma unterzeichnet 1,4-Millionen-Euro-Vertrag für deutsche Cannabisversorgung
Das Unternehmen vertreibt seine Produkte inzwischen in mehreren europäischen Ländern, darunter im Vereinigten Königreich, Italien und Dänemark.
- Policy & Regulation
Albania proposes law to regulate cannabis
Albania could join a number of European countries moving toward implementing progressive cannabis policy.
- Policy & Regulation
Italy’s cannabis prohibition debate continues
Despite the rejection of a referendum on the topic, the impact of the prohibition of cannabis in Italy continues to be discussed.
- CBD Market
Amazon’s CBD pilot sees further listings
High Tide subsidiary, Blessed CBD, has had its products added to the pilot.
- Adult-Use
Crafting cannabis policy to adhere to European and international regulations
A new white paper discusses the obligations and flexibilities of the cannabis industry under European and international law.
- Medical
Cannabis company receives approval for Covid-19 trial
MGC Pharma has received approvals from the South African Health Products Regulatory Authority.
- Adult-Use
Cannabis Europa: equity must come first in the cannabis industry
“We need to end criminal sanctions for cannabis,” says drug reform expert.
- CBD Market
Cannabotech sees 24 products included on FSA CBD list
Cannabotech products have also been submitted for registration as Novel Food at the European Food Safety Authority (EFSA).
- CBD Market
British Cannabis™ now largest manufacturer of products on UK CBD list
The company now manufactures 12.4 per cent of all CBD food supplements included on the FSA’s public list.
- CBD Market
B3 Labs receives Novel Foods accreditation
The Manchester-based company has had its product portfolio added to the UK’s public list of CBD products.
- Companies
Khiron continues expansion into Spain after medical bill green light
Khiron will continue its long-standing relationship with the Spanish Agency of Medicines and Medical Devices (AEMPS).
